Snakebites affect about 1.8 million people annually. The current standard of care involves
antibody-based antivenoms, which can be difficult to access and are generally not effective …

Snake venom proteins have long been recognized for their therapeutic potential.
Proteogenomic strategies, integrating transcriptomics and proteomics, have emerged as …

Cytotoxins (CTs) are three-finger membrane-active toxins present mainly in cobra venom.
Our analysis of the available CT amino acid sequences, literature data on their membrane …

Abstract The North African mountain viper (Vipera monticola) is a medically relevant
venomous snake distributed in Morocco, Algeria, and Tunisia. Three subspecies of V …

Snakebite envenoming and its resulting complications are serious threats to the health of
vulnerable people living in rural areas of develo** countries. The knowledge of the …

Snakebite envenomation is a major public health issue which causes severe morbidity and
mortality, affecting millions of people annually. Of a diverse range of clinical manifestations …

Snakebite-associated acute kidney injury (AKI) poses a significant health burden in the
South Asia region, resulting in considerable morbidity and mortality. Multiple factors …

In this work, we describe an easy, simple, and cost-effective method to assess the proteolytic
activity of snake venoms. The method is based on measuring the hydrolytic halo formed by …

Background Bothrops venom consists primarily of metalloproteinase and phospholipase A2
toxins, which are responsible for the acute inflammatory, coagulant and hemorrhagic action …

The variation in venom between and within snake species has significant implications for
snakebite treatment. This highlights the critical importance of studying venom composition …